CIRM Funded Clinical Trials
Phase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect
Disease Area:
Corneal Damage
Trial Sponsor:
Combangio, Inc.
Trial Stage:
Phase 2
Trial Status:
Launching
Targeted Enrollment:
N/A
